The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics

Diabetologia

Volumn 58, Issue 7, 2015, Pages 1436-1442

  Lappas, Martha ^a,b   Mundra, Piyushkumar A ^c   Wong, Gerard ^c   Huynh, Kevin ^c   Jinks, Debra ^b   Georgiou, Harry M ^a,b   Permezel, Michael ^a,b   Meikle, Peter J ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MERCY HOSPITAL FOR WOMEN   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Gestational diabetes mellitus; Lipids; Type 2 diabetes

Indexed keywords

CERAMIDE; CERAMIDE TRIHEXOSIDE; CHOLESTEROL ESTER; GANGLIOSIDE GM3; GLUCOSE; LIPID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; SPHINGOMYELIN; TRIACYLGLYCEROL; CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; COHORT ANALYSIS; DISEASE ASSOCIATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FOLLOW UP; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID BLOOD LEVEL; LIPIDOMICS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; TANDEM MASS SPECTROMETRY; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; GLUCOSE TOLERANCE TEST; PREGNANCY; RISK ASSESSMENT; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL ESTERS; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMANS; LIPIDS; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLSERINES; PREGNANCY; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; TRIGLYCERIDES; YOUNG ADULT;

EID: 84931572631     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3587-7     Document Type: Article

References (30)

1. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14
2. Roglic G, Unwin N, Bennett PH et al (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 28:2130–2135
3. Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 8:228–236
4. Hossain P, Kawar B, El Nahas M (2007) Obesity and diabetes in the developing world—a growing challenge. N Engl J Med 356:213–215
5. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M (2007) Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30:878–883
6. Akinci B, Celtik A, Yener S, Yesil S (2010) Prediction of developing metabolic syndrome after gestational diabetes mellitus. Fertil Steril 93:1248–1254
7. Bo S, Monge L, Macchetta C et al (2004) Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Investig 27:629–635
8. Lappas M, Jinks D, Ugoni A, Louizos CC, Permezel M, Georgiou HM (2014) Postpartum plasma C-peptide and ghrelin concentrations are predictive of type 2 diabetes in women with previous gestational diabetes mellitus. J Diabetes. doi:10.1111/1753-0407.12209
9. Bonora E, Targher G, Alberiche M et al (2002) Predictors of insulin sensitivity in type 2 diabetes mellitus. Diabet Med 19:535–542
10. Joseph J, Svartberg J, Njolstad I, Schirmer H (2011) Risk factors for type 2 diabetes in groups stratified according to metabolic syndrome: a 10-year follow-up of the Tromso Study. Eur J Epidemiol 26:117–124
11. Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639–648
12. Wong G, Barlow CK, Weir JM et al (2013) Inclusion of plasma lipid species improves classification of individuals at risk of type 2 diabetes. PLOS ONE 8:e76577
13. Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167
14. Weir JM, Wong G, Barlow CK et al (2013) Plasma lipid profiling in a large population-based cohort. J Lipid Res 54:2898–2908
15. Anderson SG, Dunn WB, Banerjee M et al (2014) Evidence that multiple defects in lipid regulation occur before hyperglycemia during the prodrome of type-2 diabetes. PLOS ONE 9:e103217
16. Meikle PJ, Wong G, Barlow CK et al (2013) Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLOS ONE 8:e74341
17. Meikle PJ, Wong G, Barlow CK, Kingwell BA (2014) Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease. Pharmacol Ther 143:12–23
18. Rhee EP, Cheng S, Larson MG et al (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121:1402–1411
19. Boon J, Hoy AJ, Stark R et al (2013) Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes 62:401–410
20. de Mello VD, Lankinen M, Schwab U et al (2009) Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease. Diabetologia 52:2612–2615
21. Boslem E, MacIntosh G, Preston AM et al (2011) A lipidomic screen of palmitate-treated MIN6 beta-cells links sphingolipid metabolites with endoplasmic reticulum (ER) stress and impaired protein trafficking. Biochem J 435:267–276
22. Manukyan L, Ubhayasekera SJ, Bergquist J, Sargsyan E, Bergsten P (2015) Palmitate-induced impairments of beta-cell function are linked with generation of specific ceramide species via acylation of sphingosine. Endocrinology 156:802–812
23. Boslem E, Meikle PJ, Biden TJ (2012) Roles of ceramide and sphingolipids in pancreatic beta-cell function and dysfunction. Islets 4:177–187
24. Lessig J, Fuchs B (2009) Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Curr Med Chem 16:2021–2041
25. Maeba R, Ueta N (2003) Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers. J Lipid Res 44:164–171
26. Mankidy R, Ahiahonu PW, Ma H et al (2010) Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study. Lipids Health Dis 9:62
27. Meikle PJ, Wong G, Tsorotes D et al (2011) Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol 31:2723–2732
28. Barden A, Singh R, Walters B, Phillips M, Beilin LJ (2013) A simple scoring method using cardiometabolic risk measurements in pregnancy to determine 10-year risk of type 2 diabetes in women with gestational diabetes. Nutr Diabetes 3, e72
29. Ratner RE, Christophi CA, Metzger BE et al (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93:4774–4779
30. Buchanan TA, Xiang AH, Peters RK et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51:2796–2803